00736nam a22002292  4500001001300000003000500013005001700018008004100035040001800076086002500094099002500119245013100144260003000275300000700305490002400312500003000336500004400366650002200410710003700432949001800469999001900487hsl001007267DGPO20170826152558.0170117s1975    dcu          f000 0 eng d  aGPOcGPOdMvI0 aHE 20.3161/A:R 118/4  aHE 20.3161/A:R 118/400aSerum levels of N2,N2 dimethylguanosine and pseudouridine as determined by radioimmunoassay for patents [sic] with malignancy.  a[Washington, D.C.,c1975]  av.0 aBrief communication  aReprinted from JNCI 54,2.  aCRDP Program Historic Shelflist record. 0aCancerxResearch.2 aNational Cancer Institute (U.S.)  aBEVbFed Docs  c264682d264682